Programmable core-shell microneedles with marine chondroitin sulfate core and chito-oligosaccharide shell disrupt the pathological microenvironment cycle for enhanced healing of infected burn wounds

  • Int J Biol Macromol. 2026 Jul:370:152860. doi: 10.1016/j.ijbiomac.2026.152860.
Min Li  1 Yong Jiang  2 Jiqing Dong  1 Linlin Ma  1 Yuehao Xu  1 Xiangyan Chen  3 Yantao Li  4
Affiliations
  • 1. State Key Laboratory of Advanced Optical Polymer and Manufacturing Technology, Qingdao Key Laboratory of Biomacromolecular Drug Discovery and Development, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, 266042, China.
  • 2. Department of Burns and Plastic Surgery, No.971 hospital of the people's Liberation Army Navy, Qingdao, 266071, China.
  • 3. State Key Laboratory of Advanced Optical Polymer and Manufacturing Technology, Qingdao Key Laboratory of Biomacromolecular Drug Discovery and Development, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, 266042, China. Electronic address: [email protected].
  • 4. State Key Laboratory of Advanced Optical Polymer and Manufacturing Technology, Qingdao Key Laboratory of Biomacromolecular Drug Discovery and Development, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, 266042, China. Electronic address: [email protected].
Abstract

Infected burn wounds are difficult to heal due to a self-sustaining cycle of Infection, inflammation, oxidative stress, and pain that disrupts orderly tissue regeneration. Herein, we develop a programmable marine polysaccharide-based core-shell microneedle patch (CC-MN) that effectively disrupts this pathological cycle through stage-specific therapeutic regulation. The CC-MN integrates a chito-oligosaccharide (COS) shell and a chondroitin sulfate (CS) core. Its programmability is encoded by the core-shell architecture, enabling rapid COS shell dissolution for early-stage Antibacterial intervention, followed by sustained CS core release for prolonged immunomodulatory and pro-regenerative regulation. Specifically, CC-MN achieved Antibacterial inhibition rates of 94.0%, 98.8%, and 99.5% against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, respectively. Meanwhile, sustained CS release attenuated inflammation, scavenged excessive Reactive Oxygen Species, reduced pain-associated inflammatory mediators including prostaglandin E2, and promoted macrophage polarization toward a pro-regenerative phenotype. In a Pseudomonas aeruginosa-infected burn wound model, CC-MN treatment reduced wound Bacterial burden to ~0.5% of the untreated control and accelerated wound closure to 96.1% by day 16, accompanied by decreased inflammatory cytokine expression, enhanced angiogenesis, and improved Collagen remodeling. This work presents a translatable and programmable microneedle platform for comprehensive management of infected burn wounds.

Keywords
Antibacterial therapy; Burn wounds; Core-shell microneedles; Marine polysaccharides; Oxidative stress.
Products